Yarrow (Achillea millefolium L.) Extract Produces Beneficial effects on Reproductive Parameters in Estradiol Valerate-Induced Polycystic Ovarian Syndrome in Rats

Document Type : Original Article


1 Department of basic sciences, School of Veterinary Medicine, Tehran University of Medical Sciences, Tehran, Iran

2 Neuroscience Research Center, Qom University of Medical Sciences, Qom, Iran

3 Dept. of Anatomical Sciences, School of Medicine, AJA University of Medical Sciences, Tehran, Iran

4 3Dept. of Anatomical Sciences, School of Medicine, AJA University of Medical Sciences, Tehran, Iran

5 Department of Physiology and Iranian medicine, School of Medicine, AJA University of Medical science, Tehran, Iran


Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders with a spread of around 10% in the world. Yarrow (Achillea millefolium L.) is a medicinal plant with essential oils, steroids, flavonoids and phenolic compounds. The aim of this study was to investigate the effects of yarrow extract on blood hormones and ovarian histology in rat model of PCOS.
Methods: Seventy rats were equally allocated into seven groups: control; control+1.2g/kg body weight (BW) yarrow extract; PCOS, induced by single-dose intramuscular injection of estradiol valerate (EV, 1 mg/100g BW); PCOS+2 mg/kg BW clomiphene citrate (CC); PCOS+1.2, 2.5 and 5g/kg BW of yarrow extract for a period of 30 days. Vaginal smear was performed for 60 days after the EV injection. Hormone assays for LH, FSH, progesterone, testosterone and estradiol, and ovarian histology were also performed.
Results: CC could moderate serum levels of FSH, estrogen and progesterone and concentrations of LH, LH/FSH and testosterone became normal, whereas CC did not have a significant effect on body and ovary weights, and number of ovarian cysts. Yarrow extract could ameliorate the body and ovary weights, cystic follicles and sex hormones in PCOS induced by EV in a dose-dependent manner. High dose of yarrow extract improved the detrimental effects of PCOS on body and ovary weights, and number of ovarian cysts, and caused them to reach normal levels.
Conclusion: Yarrow extract in 5mg/kg BW may be used as a nutritional supplement for adjunct therapy of PCOS patients.


Main Subjects

1.Eiras MC, Pinheiro DP, Romcy KAM, Ferriani RA, Dos Reis RM, Furtado CLM. Polycystic Ovary Syndrome: the Epigenetics Behind the Disease. Reprod Sci. 2021: 1-15.
2.Dunaif A. Polycystic ovary syndrome in 2011: Genes, aging and sleep apnea in polycystic ovary syndrome. Nature reviews Endocrinology. 2012; 8(2): 72.
3.Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005; 352(12): 1223-36.
4.Hunter MH, Sterrett JJ. Polycystic ovary syndrome: it's not just infertility. Am Fam Physician. 2000; 62(5): 1079-88.
5.Parker JC, Mahesh V. Interrelationship between excessive levels of circulating androgens in blood and ovulatory failure. J Reprod Med. 1976; 17(2): 75-90.
6.Popkin RM, Fraser H, Gosden R. Effects of LH-RH agonist or LH-RH immunoneutralization on pituitary and ovarian LH-RH receptors in female rats. Reproduction. 1983; 69(1): 245-52.
7.Campbell CS, Schwartz NB. The impact of constant light on the estrous cycle of the rat. Endocrinology. 1980; 106(4): 1230-38.
8.Brawer JR, Munoz M, Farookhi R. Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat. Biol Reprod. 1986; 35(3): 647-55.
9.Dickey RP, Taylor SN, Curole DN, Rye PH, Pyrzak R. Infertility: Incidence of spontaneous abortion in clomiphene pregnancies. Hum Reprod. 1996; 11(12): 2623-8.
10.Diedrich K, Collins J, Baird D, Evers JL, Crosignani P, Tarlatzis B, et al. Female infertility: treatment options for complicated cases. Hum Reprod. 1997; 12(6): 1191-6.
11.Ghazeeri G, Kutteh WH, Bryer-Ash M, Haas D, Ke RW. Effect of rosiglitazone on spontaneous and clomiphene citrate–induced ovulation in women with polycystic ovary syndrome. Fertil Steril. 2003; 79(3): 562-6.
12.Bahmanpour S, Bakhtari A, Abouhamzeh B. Protective Effect of Vitrified-warmed Media with Clove Bud (Syzygium aromaticum) Extract on Mouse Oocytes And Resultant Blastocysts. CryoLetters. 2018; 39(5): 288-97.
13.Goswami PK, Khale A, Ogale S. Natural remedies for polycystic ovarian syndrome (PCOS): a review. Int J Pharm Phytopharmacological Res. 2012; 1(6): 396-402.
14.Pachiappan S, Matheswaran S, Pushkalai P. Medicinal plants for polycystic ovary syndrome: A review of phytomedicine research. Int J Herb Med. 2017; 5: 78-80.
15.Mitich LW. Yarrow–the herb of Achilles. Weed Technol. 1990; 4(2): 451-53.
16.Applequist WL, Moerman DE. Yarrow (Achillea millefolium L.): a neglected panacea? A review of ethnobotany, bioactivity, and biomedical research. Econ Bot. 2011; 65(2): 209.
17.Boswell‐Ruys CL, Ritchie HE, Brown‐Woodman PD. Preliminary screening study of reproductive outcomes after exposure to yarrow in the pregnant rat. Birth Defects Res B Dev Reprod Toxicol. 2003; 68(5): 416-20.
18.Dalsenter PR, Cavalcanti AM, Andrade AJ, Araújo SL, Marques MC. Reproductive evaluation of aqueous crude extract of Achillea millefolium L.(Asteraceae) in Wistar rats. Reprod Toxicol. 2004; 18(6): 819-23.
19.Mehraban M, Jelodar G, Rahmanifar F. A combination of spearmint and flaxseed extract improved endocrine and histomorphology of ovary in experimental PCOS. Journal of ovarian research. 2020; 13(1): 1-8.
20.Ahangarpour A, Heidari H, Junghani MS, Absari R, Khoogar M, Ghaedi E. Effects of hydroalcoholic extract of Rhus coriaria seed on glucose and insulin related biomarkers, lipid profile, and hepatic enzymes in nicotinamide-streptozotocin-induced type II diabetic male mice. Res Pharm Sci. 2017; 12(5): 416.
21.Salvetti NR, Canal AM, Gimeno EJ, Ortega HH. Polycystic ovarian syndrome: temporal characterization of the induction and reversion process in an experimental model. Braz J Vet Res Anim Sci. 2004; 41(6): 389-95.
22.Myers M, Britt KL, Wreford NGM, Ebling FJ, Kerr JB. Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004; 127(5): 569-80.
23.Radavelli-Bagatini S, Blair AR, Proietto J, Spritzer PM, Andrikopoulos S. The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function. J Endocrinol. 2011; 209(3): 307-15.
24.March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010; 25(2): 544-51.
25.Elizabeth M, Leslie NS, Critch EA. Managing polycystic ovary syndrome: a cognitive behavioral strategy. Nurs Womens Health. 2009; 13(4): 292-300.
26.Walters KA, Allan CM, Handelsman DJ. Rodent models for human polycystic ovary syndrome. Biol Reprod. 2012; 86(5): 149, 112-41.
27.Requena A, Herrero J, Landeras J, Navarro E, Neyro JL, Salvador C, et al. Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update. 2008; 14(6): 571-82.
28.Isobe N, Kitabayashi M, Yoshimura Y. Microvascular distribution and vascular endothelial growth factor expression in bovine cystic follicles. Domest Anim Endocrinol. 2005; 29(4): 634-45.
29.Pandey V, Singh A, Singh A, Krishna A, Pandey U, Tripathi YB. Role of oxidative stress and low-grade inflammation in letrozole-induced polycystic ovary syndrome in the rat. Reprod Biol. 2016; 16(1): 70-7.
30.Dickey RP, Olar TT, Taylor SN, Curole DN, Rye PH. Sequential clomiphene citrate and human menopausal gonadotrophin for ovulation induction: comparison to clomiphene citrate alone and human menopausal gonadotrophin alone. Hum Reprod. 1993; 8(1): 56-9.
31.Choi HD, Kim JH, Chang MJ, Kyu‐Youn Y, Shin WG. Effects of astaxanthin on oxidative stress in overweight and obese adults. Phytother Res. 2011; 25(12): 1813-18.
32.Agarwal A, Gupta S, Sekhon L, Shah R. Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008; 10(8): 1375-04.
33.Mouhid L, Gómez de Cedrón M, Quijada-Freire A, Fernández-Marcos PJ, Reglero G, Fornari T, et al. Yarrow Supercritical Extract Ameliorates the Metabolic Stress in a Model of Obesity Induced by High-Fat Diet. Nutrients. 2020; 12(1): 72.
34.Mouhid L, de Cedron MG, García-Carrascosa E, Reglero G, Fornari T, de Molina AR. Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer. PLoS One. 2019; 14(3).
35.Milutinović M, Radovanović N, Ćorović M, Šiler-Marinković S, Rajilić-Stojanović M, Dimitrijević-Branković S. Optimisation of microwave-assisted extraction parameters for antioxidants from waste Achillea millefolium dust. Ind Crops Prod. 2015; 77: 333-41.
36.Yoon K, Kwack SJ, Kim HS, Lee BM. Estrogenic endocrine-disrupting chemicals: molecular mechanisms of actions on putative human diseases. J Toxicol Environ Health B. 2014; 17(3): 127-74.
37.Weber K, Setchell K, Stocco D, Lephart E. Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague-Dawley rats. J Endocrinol. 2001; 170(3): 591-9.
38.Atashpour S, Jahromi HK, Jahromi ZK, Maleknasab M. Comparison of the effects of Ginger extract with clomiphene citrate on sex hormones in rats with polycystic ovarian syndrome. Int J Reprod Biomed. 2017; 15(9): 561.
39.Zangeneh FZ, Minaee B, Amirzargar A, Ahangarpour A, Mousavizadeh K. Effects of chamomile extract on biochemical and clinical parameters in a rat model of polycystic ovary syndrome. J Reprod Infertil. 2010; 11(3): 169.
40.Ghafurniyan H, Azarnia M, Nabiuni M, Karimzadeh L. The effect of green tea extract on reproductive improvement in estradiol valerate-induced polycystic ovarian syndrome in rat. Iranian journal of pharmaceutical research: IJPR. 2015; 14(4): 1215.